Brief: Adocia Files Patent For Technology To Enable Oral Drug Delivery Of Peptides

Adocia SA

13/12/2021 17:16

Dec 13 (Reuters) - Adocia SA  ADOC.PA :
    * FILES PATENT FOR TECHNOLOGY TO ENABLE ORAL DRUG DELIVERY
OF
PEPTIDES
    * ITS TECHNOLOGY HAS SHOWN PROMISING IN VIVO RESULTS WITH
ORAL
ADMINISTRATION OF A GLP-1 RECEPTOR AGONIST FOR TREATMENT OF
DIABETES
    * FIRST-IN-HUMAN CLINICAL STUDY PLANNED FOR 2022 TO
ESTABLISH
PROOF OF CONCEPT
    * POTENTIAL OF THIS TECHNOLOGY IS BEING ASSESSED ACROSS
DIFFERENT
THERAPEUTIC PEPTIDES AND PROTEINS

Source text for Eikon:  ID:nBw3yTl1Qa 
Further company coverage:  ADOC.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))